We offer a variety of integrated services including consultancy, study design, and research & development to the public and private sectors regarding biomarker applications in oncology.
Our team extends across several sectors: pathology, molecular genetics, statistics,
regulatory and clinical in order to address point specific issues or implement holistic solutions and/or project portfolios from pre-clinical models to clinical trials and companion diagnostics.